FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q2 2023

Top Holdings173 positions

Checking export access…
Activity:
SPYSPY
PUT

State Street Spdr S&P 500 Etf

7.2M$3.2B16.0%———
Increased
—

Iqvia Holdings Inc

3.9M$869.2M4.4%$159.39+38.92%
19 qtrssince 2018-Q4
Increased
70

Transunion

9.3M$730.4M3.7%$86.03-11.10%
19 qtrssince 2018-Q4
Increased
63

HORIZON THERAPEUTICS PUB L

6.9M$711.9M3.6%——
9 qtrssince 2021-Q2
Increased
72

Thermo Fisher Scientific Inc

1.2M$648.9M3.3%$417.19+23.77%
15 qtrssince 2019-Q4
Increased
68

Unitedhealth Group Inc

1.3M$605M3.0%$443.19+1.45%
2 qtrssince 2023-Q1
Increased
78
VMWVMWDelisted

VMWARE INC-CLASS A

3.7M$534M2.7%——
5 qtrssince 2022-Q2
Increased
87

Exelixis Inc

25.9M$494.2M2.5%$19.21-0.52%
19 qtrssince 2018-Q4
Increased
59

Aramark

10.9M$468.7M2.4%$24.80+21.10%
11 qtrssince 2020-Q4
Decreased
0

Alphabet Inc Cap Stock Cl C

3.8M$459.9M2.3%$93.01+28.85%
19 qtrssince 2018-Q4
Decreased
0

S&P Global Inc

1.1M$435.5M2.2%$298.42+23.77%
5 qtrssince 2022-Q2
Decreased
0
AZNAZN
ADR

ASTRAZENECA PLC

6.1M$433.7M2.2%$115.41+17.80%
8 qtrssince 2021-Q3
Increased
55

Salesforce Inc

1.9M$410.8M2.1%$163.73+26.61%
15 qtrssince 2019-Q4
Decreased
0

ACTIVISION BLIZZARD INC

4.9M$410.1M2.1%——
6 qtrssince 2022-Q1
Increased
70

Analog Devices Inc

2.1M$404.2M2.0%$181.570.00%
1 qtr
New
81

Sherwin Williams Co

1.4M$365.2M1.8%$176.94+45.80%
18 qtrssince 2019-Q1
Increased
52

Wabtec Corp

3.2M$355.5M1.8%$73.13+47.51%
19 qtrssince 2018-Q4
Increased
55

Centene Corp

4.7M$319M1.6%$62.65+7.66%
14 qtrssince 2020-Q1
Decreased
0

Intuit

691,300$316.7M1.6%$381.37+17.40%
3 qtrssince 2022-Q4
Decreased
0

New York Times Co Cl A

8M$313.7M1.6%$39.93-3.68%
13 qtrssince 2020-Q2
Increased
60
$19.9B
AUM
173
Positions
Q2 2023
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+2%Q1'22$18.1B-6%Q2'22$17B-4%Q3'22$16.3B-5%Q4'22$15.5B+7%Q1'23$16.5B+1%Q2'23$16.7B
Activity profile
$ moved · Q2'23
New10%Increased49%Decreased19%Exited21%
Composition
Equity vs derivatives
Equity84%Puts16%Calls0%
Holding period
Avg 2.0 years
<1Q7%1-4Q13%1-2Y31%2Y+49%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $19.9B across 173 positions as of Q2 2023. Top holdings: SPY puts (16.0%), IQV (4.4%), TRU (3.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q2 2023 Summary

Active quarter - 17 new positions, 38 exits, 41 increased. Top move: VMW (INCREASED, conviction 87). Portfolio: $19.9B across 173 positions.

Top holdings by portfolio weight

Total AUM$17B
IQV4.36%
TRU3.67%
HZNP3.57%
TMO3.26%
UNH3.04%
VMW2.68%
EXEL2.48%
ARMK2.35%
GOOG2.31%
SPGI2.19%
Other2.18%

Portfolio allocation by GICS sector

Sectors11
Healthcare36.53%
Unknown14.85%
Financial Services14.66%
Technology14.64%
Industrials8.59%
Communication Services4.86%
Basic Materials2.35%
Real Estate1.98%
Consumer Cyclical0.98%
Utilities0.55%
Other0.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L44
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used